Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by malibukion Nov 15, 2017 12:08pm

172 Views

Post# 26968751

RE:RE:RE:Valeant Completes Sale of Obagi Medical Products

Hey guys,

Did you miss me? I was offline for a while. Here are some comments,

- Sirona re-shared its investor presentation which states the deal is in 2017. I guess they would not do so, if it was not the case.

- 90 M upfront is not realistic, whole Obagi sell was 190M. I am happy with any deal, just get it done and move forward. Lauch of the prodct in 2018 with cost support for pipeline is good enough for me.

- 30th of Nov is the next warrant deadline, I hope an announcement would come beforehand.

- It is not bad that one board member is out for Nova diabetes program. I wonder why the 2nd guy left.

- We need news, PPS harldy holds 0.14 if breaks 0.11 could be real.

GL

Bullboard Posts

Know your gold investment options, from bullion dealers to Costco